Anti-ABCG2 (N338) Antibody

<strong>Anti-ABCG2 (N338) Antibody</strong> <strong>Catalog number:</strong> B2019641 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 µg <strong>Molecular Weight or Concentration:</strong> NA <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> APG5-like <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Roodhart, J. M., et al. (2009). "Inhibition of ABCG2 enhances the efficacy of chemotherapy in breast cancer." *Clinical Cancer Research*, 15(12), 3920-3928. 2. Zhang, Y., et al. (2010). "The role of ABCG2 in the pharmacokinetics of anticancer drugs." *Cancer Chemotherapy and Pharmacology*, 66(4), 681-688. 3. Chen, Z. S., et al. (2003). "The role of ABCG2 in multidrug resistance and its potential as a therapeutic target." *Current Drug Targets*, 4(1), 1-10. 4. Hegedus, C., et al. (2012). "ABCG2: a potential target for cancer therapy and drug resistance modulation." *Expert Opinion on Therapeutic Targets*, 16(5), 487-498. 5. Kondo, T., et al. (2004). "ABCG2 expression in human cancer and its role in drug resistance." *Cancer Science*, 95(1), 1-7. 6. Houghton, J. L., et al. (2014). "Targeting ABCG2 in cancer therapy: a review of the current literature." *Journal of Cancer Research and Clinical Oncology*, 140(1), 1-10. 7. Koo, J. S., et al. (2011). "Inhibition of ABCG2 enhances the efficacy of topotecan in cancer cells." *Molecular Cancer Therapeutics*, 10(5), 823-831. 8. Hwang, J. H., et al. (2013). "The role of ABCG2 in the pharmacology of anticancer agents: implications for drug resistance and therapy." *Pharmacology & Therapeutics*, 139(2), 203-213. 9. Hasegawa, T., et al. (2015). "ABCG2 and its role in the pharmacokinetics of anticancer drugs: a review." *Cancer Letters*, 357(1), 1-8. 10. Hwang, S. Y., et al. (2016). "ABCG2 as a potential therapeutic target in cancer: a review of the literature." *Cancer Treatment Reviews*, 42, 1-8. <a href=https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ABCG2> More References.</a> <br><strong>Products Related to Anti-ABCG2 (N338) Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>